ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Broker Notes
Top brokers name 3 ASX shares to buy next week
Share Market News
What is next for ASX 200 shares after last month's upheaval?
Broker Notes
These ASX 200 shares could rise 30% to 40%
How to invest
How to turn $100 a week into $500,000 with ASX shares
Share Market News
This ASX medical device company has a Trump tariff exemption
Healthcare Shares
Brokers tip 4 ASX 200 healthcare shares to buy now
Broker Notes
Leading brokers name 3 ASX shares to buy today
Broker Notes
What does Macquarie think ResMed shares are worth?
Share Market News
5 things to watch on the ASX 200 on Monday
Broker Notes
10 best shares to buy today in Australia
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Liontown, Newmont, Paladin Energy, and ResMed shares are charging higher today
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
